Skip to content

Feasibility Evaluation of a Dance Fitness Program

A Feasibility Randomized Controlled Evaluation of a Mind-Body Dance Fitness Program for Improving Symptoms of Postpartum Depression

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06273423
Enrollment
40
Registered
2024-02-22
Start date
2024-10-31
Completion date
2025-06-30
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression

Keywords

Postpartum, Depression, Mind-body, Physical activity

Brief summary

The objective of this pilot project is to assess the feasibility, acceptability, and mental health impact of OULA for women with postpartum depression (PPD).

Detailed description

The proposed project is a pilot two-arm randomized controlled trial (RCT), with specific aims to evaluate the feasibility and acceptability of implementing an RCT of OULA (named after Missoula, MT) for the treatment of postpartum depression, and to explore between-subject changes in postpartum depression and postpartum anxiety following 8-weeks of OULA or waitlist control.

Interventions

OTHEROULA, Mind-body Physical Activity

Group dance fitness program with focus on the mind-body connection

Sponsors

Montana State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Ages 20-39 years * Have an infant 0-12 months old * Self-report clearance from provider to engage in physical activity following birth * Structured Clinical Interview for Diagnostic Statistical Manual-5-Research Version (SCID-5-RV) diagnosis of major depressive episode (MDE) with onset during pregnancy or 12 months following childbirth * Edinburgh Postnatal Depression Scale (EPDS) score of 10 or above * English speaking * OULA-naïve * If on first-line treatment for depression; antidepressant dose must be stable for 6 weeks; psychotherapy duration of treatment must be at least 4 weeks

Exclusion criteria

* Unable to be physically active * Current pregnancy * SCID-5-RV diagnosis of bipolar disorder, schizophrenia, or current substance use disorder * Active suicidal attempt or plan identified on the SCID-5-RV * Suicide attempt in the past 6 months * Concurrent participation in another group dance fitness format * No access to Internet via computer, tablet, or smart phone

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and acceptability7 monthsFeasibility will be evaluated using recruitment, retention, OULA attendance, and treatment completion data, amd intervention fidelity. Feasibility of recruitment will be assessed through the number of participants eligible for randomization, proportion of participants randomized relative to the total number of referrals, and number of participants enrolled each month. Feasibility of intervention will be evaluated through treatment completion and retention rates, Feasibility of Intervention Measure (FIM) will be used at intervention completion. Fidelity assessment will be measured by OULA instructors completing an self-evaluation checklist. Women in the OULA group will complete the 8-item Client Satisfaction Questionnaire (CSQ-8) will be collected at week 8. Acceptability will be assessed through reasons for withdrawal. Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) will be collected at week 8.

Secondary

MeasureTime frameDescription
Changes in postpartum depression7 monthsThe Edinburgh Postnatal Depression Scale will be used at baseline, weeks 4, 8, and 10 to evaluate postpartum depression.
Changes in postpartum anxiety7 monthsPostpartum Specific Anxiety Scale Research Short Form will be used at baseline, weeks 4, 8, and 10 to evaluate postpartum anxiety.

Contacts

Primary ContactTracy Hellem, PhD
tracy.hellem1@montana.edu406-243-2110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026